CELG US, Holds Breakout, strong support, good story - good chart

٢٥ يوليو ٢٠١٤

Although figures not that good as expected still very good story behind the company and holding breakout position after earnings miss. (CELG believes Otezla has achieved a market share lead for psoriatic arthritis shortly after its launch in April). Good fancy LT Buy and Hold. Downside limited.